Skip to main content

Michaelson Jennifer

Chief Scientific Officer | Chief Development Officer | See Remarks

1 company

Insider Signal Score

65
Good
Trades Analyzed
33
12M Win Rate
53.6%
Avg 3M Return
+1.8%
Avg 12M Return
-8.9%

Michaelson Jennifer is a Chief Scientific Officer at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $2.4M based on current market prices.

Holdings by Company

CGEMDec 19, 2025
Current Shares132.6K
Value$2.38M
Net Activity-160,264
Bought: 0Sold: 160.3K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Dec 19, 2025
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell1,345$10.01$13,463.45-1.0%+35.1%-
Dec 18, 2025
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell2,898$9.67$28,023.66-2.1%+31.6%-
Dec 15, 2025
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell3,143$12.23$38,432.74-1.1%+29.7%-
Nov 24, 2025
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell4,000$12.30$49,200.00-2.8%+8.2%-
Feb 25, 2025
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell3,756$8.53$32,038.68-2.6%-8.6%+67.8%
Jan 6, 2025
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell4,000$12.51$50,040.00-4.0%-38.5%-13.8%
Dec 18, 2024
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell4,693$11.41$53,547.13-4.5%-17.1%-7.3%
Dec 12, 2024
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell3,489$12.52$43,682.28-3.2%-25.6%-2.3%
Nov 5, 2024
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell8,000$15.64$125,120.00-6.9%-37.0%-54.3%
Sep 5, 2024
CGEM
Cullinan Therapeutics, Inc.
Chief Scientific OfficerSell8,000$18.09$144,720.00-6.5%-27.7%-61.0%
Page 1Next →